Brazil Veterinary Vaccines Market, By Vaccine Type (Livestock Vaccines, Companion Animal Vaccines, Others); By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Others); By Route of Administration (Injection Vaccines, Oral Vaccines, Intranasal/Spray Vaccines); By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
Brazil Veterinary Vaccines Market Size Expands at Steady CAGR to Reach USD 539.12 Million & Volume of 88.93 Million Units by 2030
Brazil Veterinary Vaccines Market is flourishing because of the growing awareness about animal health and an increasing focus on healthy livestock and poultry production.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Brazil Veterinary Vaccines Market size at USD 416.66 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Brazil Veterinary Vaccines Market size to expand at a CAGR of 4.21% reaching a value of USD 539.12 million by 2030. By volume, BlueWeave estimated the Brazil Veterinary Vaccines Market size at 83.81 million units in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Brazil Veterinary Vaccines Market size to expand at a CAGR of 4.55% reaching the volume of 88.93 million units by 2030. Rising pet ownership and the incidence of zoonotic illnesses are two major growth factors for the Brazil Veterinary Vaccines Market. It is also being driven by stringent regulations requiring animal immunizations in response to the growing epidemic of livestock illness.
Opportunity - Increasing number of veterinary clinics
The Brazil Veterinary Vaccines Market is segmented into veterinary hospitals, veterinary clinics, and retail pharmacies, based on distribution channel. The veterinary clinics segment dominates the Brazil Veterinary Vaccines Market owing to the high number of visits to these clinics for regular health check-ups of pets. The veterinary hospital segment also covers a substantial market share. The growth of the segment is mainly attributed to the availability of different kinds of vaccines for different diseases and advanced care facilities. Furthermore, the availability of cheaper and lower-cost healthcare services in government veterinary hospitals also contributes to the market growth.
Brazil Veterinary Vaccines Market
Segmental Coverage
Brazil Veterinary Vaccines Market – By Technology
Based on technology, the Brazil Veterinary Vaccines Market is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and others. The live attenuated vaccines segment holds the largest share in the Brazil Veterinary Vaccines Market. The live attenuated technology is prominently used in veterinary vaccines, as they can stimulate strong immune responses with weakened disease-causing viruses and bacteria. However, the recombinant vaccines segment is anticipated to grow at the highest rate over the forecast period, because of its lower associated risks of pathogenicity and targeted action.
Competitive Landscape
Major players operating in the Brazil Veterinary Vaccines Market include Ourofino Saúde Animal, Boehringer Ingelheim, Zoetis, MSD Saúde Animal (Merck Animal Health), Ceva Saúde Animal, Hipra, Biogenesis Bago, Hertape Calier, Virbac, and Agener União.
To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Brazil Veterinary Vaccines Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Brazil Veterinary Vaccines Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.